BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
27 results:

  • 1. Cancer Stem Cells and Chemoresistance in Ewing Sarcoma.
    Dos Santos RP; Roesler R; Gregianin L; Brunetto AT; da Cunha Jaeger M; Lunardi Brunetto A; de Farias CB
    Curr Stem Cell Res Ther; 2023; 18(7):926-936. PubMed ID: 35761483
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression.
    Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
    Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway.
    Yang J; Hu Y; Wang L; Sun X; Yu L; Guo W
    Bioengineered; 2021 Dec; 12(2):11007-11017. PubMed ID: 34781817
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.
    Sarkhosh-Inanlou R; Imani M; Sam MR
    Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aggressive myoepithelial carcinoma with EWSR1-pou5f1 fusion highly responsive to Ewing sarcoma combination chemotherapy.
    Shenoy N
    Cancer; 2020 Dec; 126(24):5198-5201. PubMed ID: 33048366
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Modulating Pluripotency Network Genes with Omega-3 DHA is followed by Caspase- 3 Activation and Apoptosis in DNA Mismatch Repair-Deficient/KRAS-Mutant Colorectal Cancer Stem-Like Cells.
    Mahmoudi N; Delirezh N; Sam MR
    Anticancer Agents Med Chem; 2020; 20(10):1221-1232. PubMed ID: 32116204
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Suppressing STAT5 signaling affects osteosarcoma growth and stemness.
    Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
    Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
    Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
    Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
    Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
    Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
    Lillo Osuna MA; Garcia-Lopez J; El Ayachi I; Fatima I; Khalid AB; Kumpati J; Slayden AV; Seagroves TN; Miranda-Carboni GA; Krum SA
    Cancer Res; 2019 Mar; 79(6):1054-1068. PubMed ID: 30593524
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
    La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
    J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Patient-derived osteosarcoma cells are resistant to methotrexate.
    Dos Santos Cavalcanti A; Meohas W; Ribeiro GO; de Sá Lopes AC; Gholamin S; Razavi M; Hanae Kasai Brunswick T; Avan A; Matheus Guimarães JA; Leite Duarte ME; Kahn SA
    PLoS One; 2017; 12(9):e0184891. PubMed ID: 28934267
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
    Kelleher FC; O'Sullivan H
    Oncotarget; 2016 Jul; 7(27):42792-42804. PubMed ID: 27074562
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
    Huber S; Huettner JP; Hacker K; Bernhardt G; König J; Buschauer A
    PLoS One; 2015; 10(7):e0133743. PubMed ID: 26196503
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD.
    Salerno M; Avnet S; Bonuccelli G; Hosogi S; Granchi D; Baldini N
    PLoS One; 2014; 9(10):e110340. PubMed ID: 25329465
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; D'Anneo A; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Giordano A; Vento R
    Int J Oncol; 2014 Nov; 45(5):2013-23. PubMed ID: 25174983
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells.
    Chang Y; Zhao Y; Zhan H; Wei X; Liu T; Zheng B
    Tumour Biol; 2014 Feb; 35(2):1075-82. PubMed ID: 24006225
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.